Please wait while the formulary information is being retrieved.
PROCAINAMIDE HCL (PROCAINAMIDE HCL)
- Life-threatening ventricular tachycardia
procainamide 100 mg/mL intravenous syringe
- Dosage information is not available
Life-threatening ventricular tachycardia
- Infuse 2 mg/minute by continuous infusion route
- Infuse 6 mg/minute by continuous infusion route
- artemether-lumefantrine
- Coartem
- Corvert
- disopyramide
- dofetilide
- dronedarone
- droperidol
- fingolimod
- Geodon
- Gilenya
- ibutilide fumarate
- Multaq
- Norpace
- Norpace Cr
- Orap
- pimozide
- propafenone
- Rythmol
- Tikosyn
- ziprasidone HCl
- ziprasidone mesylate
Contraindicated
- Avelox
- Avelox Abc Pack
- Avelox In Nacl (iso-osmotic)
- Buprenex
- buprenorphine
- buprenorphine-naloxone
- Butrans
- Caprelsa
- Cipro
- Cipro In D5W
- Cipro Xr
- ciprofloxacin
- ciprofloxacin (mixture)
- ciprofloxacin in D5W
- Diskets
- Dolophine
- Fareston
- Invega
- Invega Sustenna
- Invirase
- Kaletra
- Ketek
- Levaquin
- Levaquin In 5 % Dextrose
- Levitra
- levofloxacin
- levofloxacin in D5W
- lopinavir-ritonavir
- methadone
- Methadone Intensol
- Methadose
- moxifloxacin
- moxifloxacin in NaCl (iso-osm)
- nilotinib
- norfloxacin
- Noroxin
- ofloxacin
- paliperidone
- paliperidone palmitate
- Qualaquin
- quetiapine
- quinine sulfate
- saquinavir mesylate
- Seroquel
- Seroquel Xr
- Suboxone
- Tasigna
- telithromycin
- tetrabenazine
- thioridazine
- toremifene
- vandetanib
- vardenafil
- Xenazine
- Zubsolv
Severe
Moderate
- Acid Reducer (cimetidine)
- Acid Relief (cimetidine)
- alfuzosin
- amiodarone
- amiodarone in dextrose,iso-osm
- Anzemet
- Apokyn
- apomorphine
- Bactrim
- Bactrim Ds
- cimetidine
- clozapine
- Clozaril
- Complera
- Cordarone
- dasatinib
- Detrol
- Detrol La
- dolasetron
- Edurant
- emtricitab-rilpivirine-tenofov
- Fazaclo
- Heartburn Relief
- lapatinib
- Nexterone
- Noxafil
- Pacerone
- pasireotide
- pazopanib
- posaconazole
- Primsol
- rilpivirine
- Signifor
- Sprycel
- sulfamethoxazole-trimethoprim
- Sulfatrim
- sunitinib
- Sutent
- Tagamet Hb
- tolterodine
- trimethoprim
- Tykerb
- Uroxatral
- Versacloz
- Votrient
- Complete atrioventricular block
- Congenital long QT syndrome
- Hyperkalemia
- Hypokalemia
- Prolonged QT interval
- Systemic lupus erythematosus
- Torsades de pointes
Contraindicated
- 30 day risk period post-myocardial infarction
- Agranulocytosis
- Bundle branch block
- Chronic heart failure
- Digitalis toxicity
- Hypotension
- Kidney disease with reduction in GFR
- Myasthenia gravis
- Second degree atrioventricular heart block
- Thrombocytopenic disorder
Severe
Moderate
- Disease of liver
PROCAINAMIDE HCL (PROCAINAMIDE HCL)
- Life-threatening ventricular tachycardia
- None
- Anorexia
- Diarrhea
More Frequent
Severe
Less Severe
- Allergic dermatitis
- Lupus-like syndrome
- Pruritus of skin
- Skin rash
- Dizziness
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute confusion
- Agranulocytosis
- Angioedema
- Autoimmune hemolytic anemia
- Depression
- Hallucinations
- Hemolytic anemia
- Hyperbilirubinemia
- Hypotension
- Increased alanine transaminase
- Increased aspartate transaminase
- Leukopenia
- Neutropenic disorder
- Prolonged QT interval
- Thrombocytopenic disorder
- Torsades de pointes
- Ventricular fibrillation
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Procainamide (Injection)
Monitor serum concentration and titrate dose to patient response.
- 1 Day – 29 Days
- Monitor serum concentration and titrate dose to patient response.
Procainamide Hydrochloride
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Procainamide Hydrochloride
Limited data suggest minimal excretion, insuff data avail
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Limited data suggest minimal excretion, insuff data avail |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Procainamide Hydrochloride
Cardiovascular-High serum levels will prolong the QT interval. Elderly are more sensitive to hypotensive effects therefore dose reduction may be necessary. Renal-Use caution in renal impairment. Follow serum levels.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | Y | N | N | N |
BEERS: N HEDIS: N STOPP: Y
No Known Risk
None
- None
| Life-threatening ventricular tachycardia | |
| I47.2 | Ventricular tachycardia |
| 0-9 | A-Z |
|---|---|
| I47.2 | Ventricular tachycardia |
Formulary Reference Tool